Bladder Cancer - Results from #380

REVIEW UroToday

Use of Bladder Epicheck® in the follow-up of high-risk non-muscle-invasive bladder cancer: A systematic literature review. May 15, 2024

Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial. May 15, 2024

Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France. May 14, 2024

Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer. May 14, 2024

Does intravesical BCG for bladder cancer protect from COVID-19? May 14, 2024

Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era. May 13, 2024

Practice patterns and survival outcomes for Muscle-Invasive Bladder Cancer: real-life experience in a general population setting. May 13, 2024

J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan. May 13, 2024

Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols. May 13, 2024

Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel. May 13, 2024

Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization. May 10, 2024

Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin. May 10, 2024

The Potential Role of Urinary Microbiota in Bladder Carcinogenesis: A Systematic Review. May 9, 2024

Evaluation of magnetic resonance imaging for bladder cancer detection following transurethral resection of bladder tumour (TURBT). May 9, 2024

Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor. May 9, 2024

A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria. The Safe Testing of Risk for Asymptomatic Microhematuria Trial May 8, 2024

Grade Heterogeneity in High-Grade Urothelial Carcinomas: Does It Have an Impact on the Survival of Patients With Intermediate/High-Risk Nonmuscle-Invasive Bladder Cancer Who Received Adequate Adjuvant Bacillus Calmette-Guérin Therapy? May 8, 2024

Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer. May 8, 2024

Management of urothelial cancer in patients with chronic kidney disease receiving platinum-based chemotherapy. May 8, 2024

Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer: An analysis of the National Surgical Quality Improvement Program (NSQIP) procedure targeted cystectomy database. May 7, 2024

Page 20 of 517